Foreign Policy Examines India’s Growing Industry Of Fertility Treatment

Foreign Policy examines “India’s flourishing fertility treatment business,” a multi-billion dollar industry that “has earned India the dubious reputation of being the world’s baby factory.” While “regulation has not kept pace with the proliferation of clinics” and some “facilities have been accused of a litany of shocking abuses,” “[t]he Indian government is gearing up to pass a new law to regulate the fertility business,” the magazine writes. The article focuses on “one pressing issue [that] has remained beyond the purview of regulation: How old is too old to get pregnant?” and discusses post-menopausal aged women undergoing in vitro fertilization (IVF) and other fertility treatments in order to become pregnant (Chopra, 2/10).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

KFF Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270 | Email Alerts: | |

The independent source for health policy research, polling, and news, KFF is a nonprofit organization based in San Francisco, California.